Amyloidosis is a systemic disease caused by low molecular weight protein accumulation in
the extracellular space, which can lead to different degrees of damage, depending of the …

Cardiac amyloidosis (CA) is a condition caused by extracellular deposition of amyloid fibrils
in the heart. It is an underdiagnosed disease entity which can present with a variety of …

Background and aims The discordance between QRS voltages on electrocardiogram (ECG)
and left ventricle (LV) wall thickness (LVWT) on echocardiogram (echo) is a recognized red …

Background Chest pain is experienced by patients with cardiac amyloidosis (CA), but a
systematic investigation of its frequency, underlying etiologies and clinical significance is …

Background The introduction of a noninvasive diagnostic algorithm in 2016 led to increased
awareness and recognition of cardiac amyloidosis (CA). Objectives The purpose of this …

Introduction and objectives: Transthyretin cardiac amyloidosis (ATTR-CA) is a frequent
cause of heart failure with preserved ejection fraction (HFpEF). This study aimed to …

Background Fabry disease (FD) and transthyretin cardiac amyloidosis (TTR CA) are
cardiomyopathies with hypertrophic phenotype that share several features, including left …

Background Amyloidosis is a rare multi-system disorder associated with frequently delayed
diagnosis, enormous disease burden and psychosocial distress. Methods Systematic …

Introduction Amyloidosis, a polymeric deposition disease classified according to protein
subtype, may have varied pulmonary manifestations. Its anatomic-radiologic phenotypes …

Purpose While early diagnosis is crucial, as new treatments can significantly slow the
progression of the disease, there is growing evidence on the application of novel imaging …